PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
164.83%
Revenue growth exceeding 1.5x VET's 6.56%. David Dodd would verify if faster growth reflects superior business model.
139.28%
Cost growth above 1.5x VET's 23.08%. Michael Burry would check for structural cost disadvantages.
195.15%
Gross profit growth exceeding 1.5x VET's 3.92%. David Dodd would verify competitive advantages.
11.45%
Margin expansion while VET shows decline. John Neff would investigate competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
185.88%
Other expenses change of 185.88% while VET maintains costs. Bruce Berkowitz would investigate efficiency.
244.08%
Operating expenses growth above 1.5x VET's 14.28%. Michael Burry would check for inefficiency.
169.98%
Total costs growth above 1.5x VET's 16.74%. Michael Burry would check for inefficiency.
No Data
No Data available this quarter, please select a different quarter.
191.13%
D&A growth above 1.5x VET's 11.21%. Michael Burry would check for excessive investment.
163.04%
EBITDA growth exceeding 1.5x VET's 2.63%. David Dodd would verify competitive advantages.
-13.48%
Both companies show margin pressure. Martin Whitman would check industry conditions.
147.80%
Operating income growth while VET declines. John Neff would investigate advantages.
-6.43%
Both companies show margin pressure. Martin Whitman would check industry conditions.
352.44%
Other expenses growth while VET reduces costs. John Neff would investigate differences.
219.47%
Pre-tax income growth while VET declines. John Neff would investigate advantages.
20.64%
Pre-tax margin growth while VET declines. John Neff would investigate advantages.
100.04%
Tax expense growth while VET reduces burden. John Neff would investigate differences.
262.73%
Net income growth while VET declines. John Neff would investigate advantages.
36.97%
Net margin growth while VET declines. John Neff would investigate advantages.
100.00%
EPS growth while VET declines. John Neff would investigate advantages.
95.12%
Diluted EPS growth while VET declines. John Neff would investigate advantages.
13.18%
Share count reduction below 50% of VET's 0.73%. Michael Burry would check for concerns.
15.39%
Diluted share reduction below 50% of VET's 0.56%. Michael Burry would check for concerns.